Código: TL04

Área Técnica: Glaucoma

INSTITUIÇÃO ONDE FOI REALIZADO O TRABALHO

• Principal: UCSD
• Secundaria: UNIFESP

AUTORES

• CAROLINA PELEGRINI BARBOSA GRACITELLI (Interesse Comercial:NÃO)
• Linda M. Zangwill (Interesse Comercial:NÃO)
• Alberto Diniz-Filho (Interesse Comercial:NÃO)
• Ricardo Y. Abe (Interesse Comercial:NÃO)
• Robert N. Weinreb (Interesse Comercial:NÃO)
• Christopher A. Girkin (Interesse Comercial:NÃO)
• Jeffrey M. Liebmann (Interesse Comercial:NÃO)
• Felipe A. Medeiros (Interesse Comercial:NÃO)

Título

DETECTION OF GLAUCOMA PROGRESSION IS DELAYED IN AFRICAN DESCENT COMPARED TO EUROPEAN DESCENT SUBJECTS

Objetivo

We investigated the time to detect visual field progression in a cohort of AD and ED glaucoma patients followed over time.

Método

The study included 445 eyes of 322 ED subjects and 334 eyes of 233 AD subjects recruited from the African Descent and Glaucoma Evaluation Study (ADAGES). Eyes had glaucomatous visual field loss on standard automated perimetry (SAP) at baseline and were followed for an average of 8.0 ± 3.4 years with an average of 12.4 ± 5.9 SAP tests. Ordinary least squares linear regression (OLS) was used to regress SAP mean deviation values over time. Residuals were extracted from OLS regression to represent expected variability estimates for levels of mean deviation (MD). Distributions of residuals for each level of MD were obtained for each racial group. Empirical cumulative distribution functions (CDF) were built to investigate the probability of detecting progression (i.e., statistically significant slope) over time.

Resultado

When controlling for the fitted (“true”) MD level and age, absolute residuals on existing data were significantly larger in AD versus ED patients (mean difference: 0.15dB; P<0.001). A significant interaction between MD level and race was seen, suggesting that AD subjects had greater increase in variability with worsening disease as compared to ED (P=0.022). When simulations were performed assuming baseline MD of -5dB, true rate of progression of -0.25dB/year (average rate of change in the cohort) and 1-year testing interval, the median time to detect progression (TTP) was significantly longer in AD versus ED (difference=4.76 years; P<0.05).

Conclusão

Our results suggest that, due to increased visual field variability, detection of glaucoma progression may be significantly delayed in AD versus ED glaucoma patients. This could explain, at least in part, higher incidence of glaucoma-related visual impairment in AD compared to ED subjects.